Medical News

RSS

Growth and profitability of health insurers continue to be under pressure

As health insurers struggle with pricing resistance from employers and decreases in enrollment in group health employee benefit plans, health insurer growth and profitability continues to be under pressure, according to a new industry forecast by Conning Research & Consulting.

8 Jan 2010

Prolia drug expected to garner blockbuster sales in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the U.S. Food and Drug Administration's (FDA) recent request for postmarketing surveillance of Amgen's Prolia, the drug's expected launch this year in the United States and Europe for the treatment of osteoporosis will drive Prolia to garner blockbuster sales in 2018..

8 Jan 2010

Manual of ethical best practices for healthcare documentation businesses now available

Heightened privacy and security concerns, increased calls for transparency of operations, and a growing home-based workforce have prompted The Association for Healthcare Documentation Integrity (AHDI) and The Medical Transcription Industry Association (MTIA) to create their Manual of Ethical Best Practices for the Healthcare Documentation Sector.

8 Jan 2010

Young Caribbean girl receives complex surgery for rare spinal condition

As part of an annual Orthopedic Surgery Mission to St. Vincent & the Grenadines, a young girl from St. Vincent in the Caribbean has received a rare in-country complex repair procedure for her spine after waiting several years on a waiting list to come to the US for treatment.

8 Jan 2010

Survey reveals compliance spending remains stronger than anticipated

Anyone doubting the commitment of business to compliance and ethics will be surprised by the findings of a survey which reveals spending on compliance has remained stronger than anticipated. Roughly three out of four companies either kept compliance spending even or actually increased it in 2009, and for 2010 the prognosis is even brighter.

8 Jan 2010

NextGen Healthcare Information Systems executes agreement with Jordan Valley Community Health Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today announced it has executed an agreement with Jordan Valley Community Health Center to deploy NextGen® EPM (Enterprise Practice Management), NextGen EHR (Electronic Health Record) and the NextMD® patient portal, as well as Quality Systems’ integrated EDR (Electronic Dental Record).

8 Jan 2010

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

ACCESS PHARMACEUTICALS, INC., today announced that it has completed enrollment and evaluation of the last additional cohort of patients in the ongoing clinical study of ProLindac as a monotherapy in ovarian cancer patients who have received at least two prior platinum based treatment regimens.

8 Jan 2010

Aneeve Nanotechnologies selected to work in the UCLA on-campus Technology Incubator Program

Aneeve Nanotechnologies LLC has been selected to work in the UCLA on-campus Technology Incubator Program at the California NanoSystems Institute. The startup company will conduct early-stage research for the development of a novel hormone sensor/meter for biomedical applications in the areas of infertility and menopause.

8 Jan 2010

NCD to release report on housing programs and policies for people with disabilities

The National Council on Disability (NCD) will release a report on housing programs and policies for people with disabilities at the JW Marriott Houston, 5150 Westheimer, Houston, TX, from 4:00 p.m. until 5:00 p.m. on Tuesday, January 19, 2010.

8 Jan 2010

TCRH expands its McKesson Paragon hospital information system to improve patient safety

Twin County Regional Hospital (TCRH) recently announced that it is expanding its McKesson Paragon® hospital information system to increase efficiency and help improve patient safety across the entire medical community of Galax, Va. and surrounding areas.

8 Jan 2010

Additional education to liver transplant candidates increases live donation and donor evaluation

A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.

8 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.

8 Jan 2010

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

The swine flu pandemic may be off the media’s radar screen, but business executives can ill afford to rest easy. Experts from the National Center for Critical Incident Analysis (NCCIA), who have studied how to respond to pandemics and bioterrorism attacks, warn that executives need to continue to monitor and manage unknown risk factors that might cause the flu to have a major impact upon costs and revenues.

8 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

The Canadian Cancer Society British Columbia and Yukon today called on the B.C. government to enact legislation to ban the cosmetic use of pesticides that would set a new national standard. The Society is also asking British Columbians to participate in the on-line public consultation.

8 Jan 2010

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.

8 Jan 2010

A.D.A.M. announces new online education product for K-12 market

A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and interactive education resources, today announced the availability of A.D.A.M. Inside Out, its newest online education product for the K-12 education market. A.D.A.M. Inside Out offers a unique opportunity for K-12 students to learn about the human body.

8 Jan 2010

ACP urges legislators to include provisions in health reform bill that support primary care workforce

The American College of Physicians (ACP) today sent a letter to key legislators urging them to ensure that the final health care reform bill includes provisions to support the primary care workforce.

8 Jan 2010

Ligand Pharmaceuticals receives $1 million as payment from N. V. Organon

Ligand Pharmaceuticals Incorporated announced today that it has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that expired on December 31, 2009.

8 Jan 2010

Medical News

Growth and profitability of health insurers continue to be under pressure

Prolia drug expected to garner blockbuster sales in 2018

Manual of ethical best practices for healthcare documentation businesses now available

Young Caribbean girl receives complex surgery for rare spinal condition

Survey reveals compliance spending remains stronger than anticipated

NextGen Healthcare Information Systems executes agreement with Jordan Valley Community Health Center

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

Aneeve Nanotechnologies selected to work in the UCLA on-campus Technology Incubator Program

NCD to release report on housing programs and policies for people with disabilities

TCRH expands its McKesson Paragon hospital information system to improve patient safety

Additional education to liver transplant candidates increases live donation and donor evaluation

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

Amira Pharmaceuticals achieves another development milestone in its FLAP program

A.D.A.M. announces new online education product for K-12 market

ACP urges legislators to include provisions in health reform bill that support primary care workforce

Ligand Pharmaceuticals receives $1 million as payment from N. V. Organon

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News